Research: Glucose monitors assist all diabetics
A recent study has shown that the use of continuous glucose monitoring devices, such as the Dexcom G7, benefits patients with type 2 diabetes who do not rely on insulin. The study found a significant reduction in hemoglobin A1C levels from 8.8% to 7.2% over a period of six months. It was also observed that these patients maintained blood sugar levels within the target range (70-180 mg/dL) for five additional hours per day compared to the group receiving routine care, regardless of age, gender, or other factors. The results of the study highlight the importance of adopting continuous glucose monitoring early in diabetes management to improve blood sugar control and reduce complications.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)